Literature DB >> 12574048

Making decisions about hormone replacement therapy.

Janice Rymer1, Ruth Wilson, Karen Ballard.   

Abstract

Mesh：

Year:  2003        PMID： 12574048      PMCID： PMC1125186          DOI： 10.1136/bmj.326.7384.322

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  32 in total

1.  Social and behavioural influences on the uptake of hormone replacement therapy among younger women.

Authors:  D Kuh; R Hardy; M Wadsworth
Journal:  BJOG       Date:  2000-06       Impact factor: 6.531

Review 2.  "Extracts from "Clinical evidence": Menopausal symptoms.

Authors:  J Rymer; E P Morris
Journal:  BMJ       Date:  2000-12-16

3.  Risk of endometrial cancer following estrogen replacement with and without progestins.

Authors:  E Weiderpass; H O Adami; J A Baron; C Magnusson; R Bergström; A Lindgren; N Correia; I Persson
Journal:  J Natl Cancer Inst       Date:  1999-07-07       Impact factor: 13.506

4.  Perception of future health risks in mid-aged women: estimates with and without behavioural changes and hormone replacement therapy.

Authors:  M S Hunter; I O'Dea
Journal:  Maturitas       Date:  1999-09-24       Impact factor: 4.342

5.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.

Authors:  F Grodstein; P A Newcomb; M J Stampfer
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

6.  Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Authors:  D Grady; N K Wenger; D Herrington; S Khan; C Furberg; D Hunninghake; E Vittinghoff; S Hulley
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

7.  Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.

Authors:  E B Gold; B Sternfeld; J L Kelsey; C Brown; C Mouton; N Reame; L Salamone; R Stellato
Journal:  Am J Epidemiol       Date:  2000-09-01       Impact factor: 4.897

8.  The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.

Authors:  D W Sturdee; L G Ulrich; D H Barlow; M Wells; M J Campbell; M P Vessey; B Nielsen; M C Anderson; A J Bragg
Journal:  BJOG       Date:  2000-11       Impact factor: 6.531

9.  Women's control and choice regarding HRT.

Authors:  F Griffiths
Journal:  Soc Sci Med       Date:  1999-08       Impact factor: 4.634

10.  Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups.

Authors:  N E Avis; R Stellato; S Crawford; J Bromberger; P Ganz; V Cain; M Kagawa-Singer
Journal:  Soc Sci Med       Date:  2001-02       Impact factor: 4.634
View more
  19 in total

1.  Making decisions about hormone replacement therapy: preparations containing oestrogen should not be given during treatment for breast cancer.

Authors:  Christopher P Hinton; Claire Coventry; Bridget Borrowclough
Journal:  BMJ       Date:  2003-06-21

2.  Making decisions about hormone replacement therapy: bisphosphonates should not be recommended for women aged 50.

Authors:  Susan M Ott
Journal:  BMJ       Date:  2003-06-21

Review 3.  What are the chances? Evaluating risk and benefit information in consumer health materials.

Authors:  Jacquelyn Burkell
Journal:  J Med Libr Assoc       Date:  2004-04

4.  Effect of clinical trial publicity on HRT prescribing in Ireland.

Authors:  C Usher; M Teeling; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2006-01-24       Impact factor: 2.953

Review 5.  Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Authors:  Marianne Canonico; Geneviève Plu-Bureau; Gordon D O Lowe; Pierre-Yves Scarabin
Journal:  BMJ       Date:  2008-05-20

6.  Preventive effects of kudzu root on bone loss and cartilage degradation in ovariectomized rats [corrected].

Authors:  Yunyun Luo; Shuang Zheng; Yujia Ding; Yueqin Dai; Yi Zhou; Ruifeng Xiang; Anne C Bay-Jensen; Morten A Karsdal; Per Qvist; Qinlong Zheng
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

7.  Estimated numbers of postmenopausal women treated by hormone therapy in France.

Authors:  Angèle Gayet-Ageron; Nassira Amamra; Virginie Ringa; Valérie Tainturier; Claudine Berr; Françoise Clavel-Chapelon; Cécile Delcourt; Pierre D Delmas; Pierre Ducimetière; Anne-Marie Schott
Journal:  Maturitas       Date:  2005-06-13       Impact factor: 4.342

Review 8.  Hormonal treatment, mild cognitive impairment and Alzheimer's disease.

Authors:  Joanne Ryan; Jaqueline Scali; Isabelle Carriere; Karen Ritchie; Marie-Laure Ancelin
Journal:  Int Psychogeriatr       Date:  2008-02       Impact factor: 3.878

Review 9.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life.

Authors:  Marius Jan van der Mooren; Peter Kenemans
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Benefits and harms associated with hormone replacement therapy: clinical decision analysis.

Authors:  Cosetta Minelli; Keith R Abrams; Alex J Sutton; Nicola J Cooper
Journal:  BMJ       Date:  2004-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.